KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Castle Biosciences (CSTL) Other Gross PP&E Adjustments (2018 - 2025)

Castle Biosciences' Other Gross PP&E Adjustments history spans 7 years, with the latest figure at $109.0 million for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments rose 130.77% year-over-year to $109.0 million; the TTM value through Dec 2025 reached $109.0 million, up 130.77%, while the annual FY2025 figure was $109.0 million, 130.77% up from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was $109.0 million at Castle Biosciences, up from $86.6 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $109.0 million in Q4 2025 and bottomed at $421000.0 in Q1 2022.
  • The 5-year median for Other Gross PP&E Adjustments is $16.6 million (2023), against an average of $31.0 million.
  • The largest annual shift saw Other Gross PP&E Adjustments crashed 95.64% in 2022 before it soared 2840.14% in 2023.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $10.1 million in 2021, then crashed by 45.68% to $5.5 million in 2022, then soared by 428.62% to $29.0 million in 2023, then surged by 62.7% to $47.2 million in 2024, then soared by 130.77% to $109.0 million in 2025.
  • Per Business Quant, the three most recent readings for CSTL's Other Gross PP&E Adjustments are $109.0 million (Q4 2025), $86.6 million (Q3 2025), and $74.1 million (Q2 2025).